How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research.
Parkinson’s disease
aggregation
amyloid
α-synuclein
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
28 01 2022
28 01 2022
Historique:
received:
22
12
2021
revised:
07
01
2022
accepted:
26
01
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
5
4
2022
Statut:
epublish
Résumé
While confronted with the increasing complexity of the neurobiology of Parkinson's disease (PD), we face the ever-increasing sloppiness of the conceptual definitions associated with poor methodological characterizations and the use of unacknowledged proxies, all of which are harmful contributors to the overall slow progress of PD research. In this opinion paper, I share part of my frustration, acknowledge how I participate in this trend, and propose a simple remedy. Fighting against semantic or conceptual sloppiness is of paramount importance, notably for the benefit of newcomers to the field who otherwise would take for granted the classic assertions found
Identifiants
pubmed: 35204729
pii: biom12020228
doi: 10.3390/biom12020228
pmc: PMC8961619
pii:
doi:
Substances chimiques
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Neurosci Methods. 2016 Jun 15;266:141-50
pubmed: 27039974
Chemistry. 2018 May 17;24(28):7210-7216
pubmed: 29543355
Trends Neurosci. 2016 Nov;39(11):750-762
pubmed: 27776749
J Parkinsons Dis. 2016;6(1):39-51
pubmed: 27003784
Sci Adv. 2020 Nov 11;6(46):
pubmed: 33177086
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Neurobiol Aging. 2012 Sep;33(9):2225-8
pubmed: 21813214
Nat Commun. 2013;4:2575
pubmed: 24108358
Sci Adv. 2020 May 13;6(20):eaaz9165
pubmed: 32426502
Mov Disord. 2018 Oct;33(10):1643-1646
pubmed: 30145841
J Neurosci. 2017 Oct 11;37(41):9799-9807
pubmed: 29021297
Mov Disord. 2018 Aug;33(8):1248-1266
pubmed: 29570866
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
Brain. 2019 Nov 1;142(11):3565-3579
pubmed: 31580415
Sci Adv. 2020 Oct 2;6(40):
pubmed: 33008896
Brain. 2022 Mar 14;:
pubmed: 35285474
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
J Parkinsons Dis. 2017;7(s1):S71-S85
pubmed: 28282810
Cell Tissue Res. 2018 Jul;373(1):175-182
pubmed: 29411106
J Exp Med. 2012 May 7;209(5):975-86
pubmed: 22508839
Brain Pathol. 2007 Apr;17(2):139-45
pubmed: 17388944
Nat Methods. 2007 Dec;4(12):1023-30
pubmed: 18026110
Brain Pathol. 2016 May;26(3):398-403
pubmed: 26940375
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Neuron. 2019 Aug 21;103(4):627-641.e7
pubmed: 31255487
Neurosci Lett. 1998 Jun 19;249(2-3):180-2
pubmed: 9682846
Lancet. 2021 Jun 12;397(10291):2284-2303
pubmed: 33848468
J Neurochem. 1999 Nov;73(5):2093-100
pubmed: 10537069
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Front Neurol. 2018 Jun 19;9:455
pubmed: 29971039
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
Nat Rev Neurosci. 2022 Feb;23(2):115-128
pubmed: 34907352
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6
pubmed: 19892735
Acta Neuropathol. 1998 Nov;96(5):445-52
pubmed: 9829807
Front Biosci. 2008 May 01;13:3850-6
pubmed: 18508479
Brain. 2020 May 1;143(5):1462-1475
pubmed: 32380543
Neurobiol Aging. 2010 Jan;31(1):99-103
pubmed: 18457903
Nat Commun. 2019 Dec 4;10(1):5535
pubmed: 31797870
NPJ Parkinsons Dis. 2022 Jan 13;8(1):10
pubmed: 35027576
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Neuropathology. 2007 Oct;27(5):494-506
pubmed: 18018486
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
Mov Disord Clin Pract. 2021 Aug 23;8(8):1189-1193
pubmed: 34765684